|
2024
|
Invention
|
Prmt5 inhibitors. The present invention relates to compounds of formula (I) and salts, stereoisom... |
|
2023
|
Invention
|
Cancer combination therapy including a flt3-inhibitor. The present invention is inter alia concer... |
|
|
Invention
|
Cancer combination therapy including a bcl-2 inhibitor. The present invention is inter alia conce... |
|
|
Invention
|
Modulators of the adenosine a2a and a2b receptor. The present invention relates to the compound o... |
|
2021
|
Invention
|
Tetrazole derivatives.
Substituted tetrazole derivatives are useful for the prevention and/or tr... |
|
|
Invention
|
Amide derivatives.
Substituted amide derivatives are useful for the prevention and/or treatment ... |
|
|
Invention
|
Condensed pyridine derivastives substitued by amide functions as acss2 inhibitors. The present in... |
|
|
Invention
|
Tetrazole derivatives. The present invention relates to substituted tetrazole derivatives. These ... |
|
2020
|
Invention
|
Heterocyclic compounds as modulators of stimulator of interferon genes (sting).
The present inve... |
|
|
Invention
|
Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (sting).
T... |
|
|
Invention
|
Heterocyclic compounds as modulators of stimulator of interferon genes (sting). The present inven... |
|
|
Invention
|
Functionalized heterocyclic compounds as modulators of stimulator of interferon genes (sting). Th... |
|
|
Invention
|
Thiophene derivatives.
Compounds of the formula I
Compounds of the formula I
Compounds o... |
|
|
Invention
|
Condensed thiophene derivatives as hypoxia inducible factor (hif) inhibitors. Compounds of the fo... |
|
|
Invention
|
Next-generation modulators of stimulator of interferon genes (sting).
The present invention rela... |
|
|
Invention
|
Next-generation modulators of stimulator of interferon genes (sting). The present invention relat... |
|
2019
|
Invention
|
Modulators of the adenosine a2a receptor. The present invention relates to the compounds of formu... |
|
|
Invention
|
Disubstituted alkyne derivatives. The present invention relates to disubstituted alkyne derivativ... |
|
|
G/S
|
Chemical preparations being additives for use in the manufacture of pharmaceuticals; chemical pre... |
|
|
G/S
|
Chemical preparations for use in the manufacture of
pharmaceuticals; chemical preparations for s... |
|
|
G/S
|
Chemical preparations for use in the manufacture of pharmaceuticals; Chemical preparations for sc... |
|
|
Invention
|
Modulators of stimulator of interferon genes (sting). The present invention relates to compounds ... |
|
|
Invention
|
Thiophene derivatives. Compounds of the formula I
1 denotes a mono- or bicyclic aromatic, unsatu... |
|
|
Invention
|
Thiophene derivatives. Compounds of the formula (I) in which R1, R2, R3, R4 and n have the meanin... |
|
2018
|
Invention
|
Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor.
The present invention relates t... |
|
|
Invention
|
Imidazo[1,2-a]pyrazine modulators of the adenosine a2a receptor. The present invention relates to... |
|
2016
|
Invention
|
Benzimidazole derivatives as kinase inhibitors. The present invention relates to derivatives of b... |
|
2013
|
Invention
|
Novel benzimidazole derivatives as kinase inhibitors. The present invention relates to derivative... |
|
|
Invention
|
Substituted tricyclic benzimidazoles as kinase inhibitors. Disclosed are substituted tricyclic be... |
